ABSTRACT The antimicrobial effects of aqueous garlic extract (AGE) against 133 multidrug-resistant gram-positive and gram-negative bacterial isolates, including Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Salmonella typhi, Pseudomonas aeruginosa, Escherichia coli, Shigella spp., and Proteus spp., and against 10 Candida spp. were studied. Antibacterial activity of AGE by well-diffusion and macrobroth dilution method was characterized by inhibition zones of 20.2-22.7 mm for gram-positives and 19.8-24.5 mm for gram-negatives and minimum inhibitory concentration (MIC) ranges of 15.6-48.3 mg/mL and 22.9-37.2 mg/mL, respectively. With the exception of P. aeruginosa, the observed disparity in MIC values at 24 and 48 hours was not significant (P Ͼ .05) in these isolates. The anticandidal effect of AGE resulted in a growth inhibition zone of 27.4 Ϯ 3.7 mm with no significant difference (P Ͼ .05) in MIC values at 24 and 48 hours, respectively. Minimum fungicidal concentrations were found to be 14.9 and 15.5 mg/mL, respectively, at these incubation periods. Further analysis revealed the antimicrobial efficacy of AGE to be dose and time dependent, producing five distinct time-kill profiles among the isolates tested. The results of this study support the use of garlic in health products and herbal remedies in Nigeria.
INTRODUCTION T
HE CONTINUOUS SPREAD of multidrug-resistant pathogens has become a serious threat to public health and a major concern for infection control practitioners worldwide. 1 In addition to increasing the cost of drug regimens, this scenario has paved way for the re-emergence of previously controlled diseases and has contributed substantially to the high frequency of opportunistic and chronic infection cases in developing countries. 2, 3 The slow pace of newer antibiotic development coupled with the availability of fewer antifungal agents with fungicidal actions centered on inhibition of ergosterol synthesis has provided the need to explore nature in search of phytotherapeutic agents with novel targets and mode of actions. The practice of complementary and alternative medicine is now on the increase in developing countries in response to World Health Organization directives culminating in several pre-clinical and clinical studies that have provided the scientific basis for the efficacy of many plants used in folk medicine to treat infections. 4, 5 Garlic, a member of the Allium family (Liliaceae), has been used traditionally for ages to treat a wide array of diseases, namely, respiratory infections, ulcers, diarrhea, and skin infections, to mention just a few. 6 Reuter et al. 7 reported garlic as a plant with antibiotic, anticancer, antioxidant, immunomodulatory, anti-inflammatory, hypoglycemic, and cardiovascular-protecting effects. This broad spectrum of activity has been attributed to the over 100 phytotherapeutic sulfur compounds present in varying concentrations in garlic. They include allicin and thiosulfinates, which are formed by crushing-induced metabolic action of the enzyme allicinase (a cysteine sulfoxide lyase) on the odorless amino acid allicin. 8 Variations in composition of garlic and genetic disparity among bacteria and fungi of the same or different species have been found responsible for the few inconsistencies in the antibacterial and antifungal properties of garlic extract, 9,10 necessitating the need for local antimicrobial testing of garlic. In Nigeria, most of the little work that has been done on garlic has provided the scientific basis for trypanocidal action of the plant, 11 which is not commensurate with the accelerated trend in garlic health products and herbal remedies in the country. Thus, there exists a wide gap in knowledge concerning antibacterial and antifungal profiles of this plant. As a prelude, an in vitro understanding of the antibacterial and antifungal properties of garlic against newer and re-emergent Nigerian isolates may broaden understanding of its spectrum of activity and provides scientific justification for use in therapeutic strategies against infections in the country.
The present study has investigated the antibacterial and antifungal activities of an aqueous garlic extract (AGE) against local multidrug-resistant bacteria and Candida spp.
MATERIALS AND METHODS

Garlic and aqueous extract preparation
Fresh bulbs of garlic (Allium sativum L.) were purchased from local markets in Ibadan, Nigeria. The cloves were separated and peeled to obtain the edible portion. Fifty grams of the edible portion was chopped and homogenized in 100 mL of autoclaved water in a Waring blender. The homogenate was then filtered by passage through a 25-mpore-size filter (Millipore, St. Quentin, France) to give a crude aqueous extract of 500 mg of garlic/mL. This was collected in a sterile vial and stored at 4°C until used. 12 All the isolates were clinical strains recovered from patients with burns, diarrhea, bacteremia, bronchopulmonary disorder, and urinary tract infections. Antibiogram profiles of the organisms by the disk diffusion method revealed resistance to at least three antibiotics based on National Committee for Clinical Laboratory Standards guidelines 13 (Table 1) . H. influenzae, S. pneumoniae, and S. pyogenes isolates were maintained on Robertson cooked meat medium (Oxoid, Basingstoke, UK), while the other isolates were maintained on tryptic soy agar slants at 4°C prior to use.
Bacterial isolates
Candida spp.
A total of 10 Candida spp. recovered from vaginal swabs, urine, and blood samples were selected for study. The isolates were maintained on Yeast extract Potato Dextrose (YPD) agar containing 2% (vol/vol) glucose, 2% (wt/vol) Bacto peptone (Difco, Detroit, MI), 1% yeast extract (Difco), and 1% Bacto agar (Difco) at 4°C prior to use.
Antibacterial testing
The growth response of the selected bacterial and yeast isolates to crude garlic extract (500 mg/mL) was determined by the agar-well diffusion technique. Each bacterial isolate was inoculated into tryptic soy broth (Difco) and grown overnight at 37°C. The cells were then pelleted by centrifugation (3,000 rpm for 5 minutes), washed three times with phosphate-buffered saline (pH 7.5), and adjusted to an inoculum of 10 8 colony-forming units (cfu)/mL (0.5 McFarland standard) by the same buffer. In the case of Candida spp., cultures were grown overnight in liquid YPD
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IWALOKUN ET AL. 12 b Str ϭ streptomycin; Ery ϭ erythromycin; Aug ϭ augmentin; Cef ϭ cefotaxime; Cro ϭ ceftriaxone; Tet ϭ tetracycline; Amp ϭ ampicillin; Amo ϭ amoxicillin; Kan ϭ kanamycin; Gen ϭ gentamicin; Chl ϭ chloramphenicol; Col ϭ colistin sulfate; Cot ϭ cotrimoxazole; TMP-STX ϭ trimethoprim-sulfamethoxazole. medium at 30°C, and the inoculum was adjusted to 10 8 cfu/mL.
One hundred microliters of inoculum (10 7 cells) was inoculated into 20 mL of appropriate molten agar (42°C) and subsequently poured into petri dishes. One hundred microliters of crude garlic extract was then dispensed into 6-mm precut wells (four wells per plate), and plates were incubated at 37°C in the case of bacteria and at 30°C in the case of Candida isolates. Negative control plates for bacteria were prepared by dispensing 100 L of freshly prepared 50 g/mL (wt/vol) ciprofloxacin (Oxoid) in sterile distilled water into the wells. The negative YPD plates contained wells filled with 100 L of 20 g/mL (wt/vol) fluconazole (Neimeth, Lagos, Nigeria). Wells filled with 100 L of phosphate-buffered saline served as positive control. Two ciprofloxacin-sensitive standard strains, E. coli ATCC25922 and S. aureus ATCC25923, were also inoculated in parallel with test organisms. The zones of inhibition observed were measured in millimeters after 24 hours for the bacterial isolates and 48 hours for the Candida isolates.
Minimum inhibitory concentration (MIC) determination
The MIC of the AGE against each of the tested isolates was determined by the macrobroth dilution method. AGE solutions at concentrations of 0-25 mg/mL by serial twofold serial dilutions and concentrations at 50, 45, 40, 35, and 30 mg/mL were prepared in tryptic soy broth in the case of bacteria and liquid YPD medium in the case of Candida spp. The tubes were then inoculated with 0.1 mL of cultures (10 7 cells). Uninoculated tubes containing growth medium or growth medium and extract were used as controls. The tubes were then incubated at appropriate temperatures for 24 and 48 hours. The MIC was defined as the lowest concentration of garlic extract that completely inhibited the growth of the organisms.
Minimum fungicidal concentration (MFC) determination
The MFC of the AGE was determined by plating 100-L samples from each MIC assay tube with growth inhibition onto YPD agar medium. Plates were then incubated at 30°C for 24-48 hours. The MFC was defined as the lowest concentration of garlic extract that produced three or fewer colonies after incubation. 14 
Time-kill analysis
In vitro killing of AGE against the tested isolates was investigated according to the method of Yin et al. 15 A bacterial inoculum of 10 6 cfu/mL or a yeast inoculum at 10 4 cfu/mL was seeded into 10 mL of reaction medium containing tryptic soy broth or liquid YPD and garlic extract at 1-3ϫ MIC for 24 hours at 37 or 30°C. A 100-L aliquot was removed from the culture medium every 2 hours for 12 hours for the determination of cfu/mL by the plate count technique. 16 Viable counts were read after a 24-hour incubation. Garlic-deficient assays were used as controls. The limit of detection was 20 cfu/mL. The diameters of zone of inhibition were expressed as mean Ϯ standard deviation values (mm). G indicates bacterial growth around the phosphate-buffered saline (PBS) control wells. Standard drugs used were ciprofloxacin (5 g per well) and fluconazole (2 g per well).
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a Numbers in parentheses represent the number of isolates tested. b The S. aureus strains also showed 100% resistance to cefuroxime, ceftriaxone, and cefotaxime. c The strains were beta-lactamase producers and also showed 100% resistance to penicillin (1 unit) and augmentin. d All the tested P. aeruginosa strains showed sensitivity to ciprofloxacin, while nine of the isolates were sensitive to AGE.
Statistical analysis
All the parameters measured were expressed as means Ϯ standard deviation. The difference between mean values was analyzed by Student's t test at the 5% significance level. P Ͻ .05 was considered to be significant, and P Ͼ .05 was non-significant.
RESULTS
The present study has investigated the antimicrobial activity of AGE against local bacterial and Candida isolates in Nigeria. Table 2 summarizes the result of the preliminary investigation of crude AGE at 500 mg/mL. The extract exhibited growth inhibition of both gram-positive and gramnegative bacteria on tryptic soy agar with inhibition zone diameter of 20.2-22.7 Ϯ 1.7-1.6 mm for gram-positive bacteria and 19.8-24.5 Ϯ 1.2-3.0 mm for gram-negative bacteria. Sensitivity of these isolates was further confirmed in ciprofloxacin plates (inhibition zone diameter ϭ
19.2-29.3 Ϯ 2.3-1.2 mm). Growth inhibition of Candida
isolates on YPD was also observed resulting in a zone of inhibition of 27.4 Ϯ 3.7 mm due to AGE and 29.8 Ϯ 2.6 mm due to fluconazole.
Further antibacterial activity testing of AGE by the macrobroth dilution method also revealed growth inhibition in liquid medium with MICs of 15.6-48.3 mg/mL and 22.9-37.2 mg/mL for gram-negatives and gram-positives, respectively. With the exception of P. aeruginosa, the observed disparity in MIC values at 24 and 48 hours was not significant (P Ͼ .05) in these isolates (Table 3) .
Further evaluation of the anticandidal activity of AGE was characterized by MICs of 11.9 Ϯ 5.5 and 12.5 Ϯ 5.1 mg/mL (Table 3) and MFCs of 14.9 Ϯ 7.0 and 15.5 Ϯ 6.4 mg/mL (Table 4 ) at 24 and 48 hours, respectively. AGE bacterial growth inhibition and anticandidal efficacy were observed to be dose and time dependent, producing five distinct time-kill profiles for Entobacteriaceae, Staphylococcus, Streptococcus, Haemophilus, and Candida isolates tested (Fig. 1) .
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IWALOKUN ET AL. MICs were expressed as mean Ϯ standard deviation values. t ϭ Student's t test; P ϭ probability at 5% significance level. a The S. aureus strains also showed 100% resistance to cefuroxime, ceftriaxone, and cefotaxime. b The strains were beta-lacamase producers and also showed 100% resistance to penicillin (1 unit) and augmentin. c In two of the 10 S. pyogenes isolates, MICs Ͼ50 mg/mL were observed after 48 hours of incubation in trypticase soy broth. d In nine of the 14 P. aeruginosa isolates, MICs Ͼ50 mg/mL were observed after 48 hours of incubation in trypticase soy broth. MFCs were expressed as mean Ϯ standard deviation values. t ϭ Student's t test; P ϭ probability at 5% significance level.
DISCUSSION
Garlic has been known for ages to have anti-infective properties against a wide range of microorganisms. 17 The present study has further demonstrated the antimicrobial potency of AGE against local multidrug-resistant bacteria and Candida isolates from Nigeria. A B D C E tive bacteria and Candida isolates were comparable to those elicited by ciprofloxacin and fluconazole, showing that the isolates exhibited susceptibility. This indicates that AGE has a broad spectrum of antimicrobial activity and a wide therapeutic window. The isolates tested in this study are responsible for many diseases in Nigeria, including bacteria meningitis, maxillary sinusitis, and otolaryngological diseases by S. pneumoniae, S. pyogenes, and H. influenzae, 18, 19 bronchopulmonary disorders and chronic otitis media by P. aeruginosa, 20, 21 candidiasis and vaginitis by Candida albicans, 22 nosocomial infections and bacteremia due to multidrug-resistant staphylococcal infections, 23, 24 and diarrheal diseases caused by E. coli, 25 Shigella spp., 26 and S. typhi. 27 The sensitivity of these isolates to AGE also implies that the intrinsic biosubstances in this extract are naive to the various drug resistance factors of the isolates, which include beta-lactamase expression, increased pyrrolidonylarylamidase activity, aminoglycoside-modifying enzymes, and altered ribosomal binding. 28, 29 Meanwhile, the antimicrobial potency of garlic has been attributed to its ability to inhibit toxin production and expression of enzymes for pathogenesis. 30, 31 Several studies, including those of Rees et al. 32 and Kumar and Sharma, 33 had previously demonstrated the antibacterial potency of AGE against enteropathogens such as Vibrio parahaemolyticus, E. coli, Klebsiella spp., Proteus spp., and S. aureus 7 and anticandidal effects against Candida spp. 34 In spite of geographical variation, the MICs of AGE for our isolates are consistent with those of Sivam 35 but are relatively lower than values obtained by Ross et al. 36 This antimicrobial potency disparity of garlic has been attributed to the different concentrations of individually and synergistically active biosubstances in garlic preparations coupled with their interactions with sulfhydryl agents in culture media. This phenomenon has been used to explain the stronger antimicrobial effect of allicin than garlic oil disulfides. 37 Meanwhile, allicin and other diallylsulfide compounds have been found at different concentrations in AGE determined by age and method of extract preparation. 38 The MFCs of AGE reported here are in consonance with previous anticandidal studies on pathogenic and emerging drug-resistant Candida species: C. albicans, Candida glabrata, and Candida krusei. 14, 39 It can be said that the concentration at which AGE showed growth inhibition is also fungicidal to our isolates as it displayed comparable MIC and MFC values. We monitored growth inhibition at 48 hours of incubation to investigate the possibility of cfu rebound due to extract instability or volatilization of bioactive agents in garlic, culminating in significantly increased MICs. This expectation was only observed in P. aeruginosa isolates. The susceptibility response observed of some of the P. aeruginosa isolates aligns with the finding of Tsao and Yin 40 but at variance with the work of Kivanc and Kunduhoglu. 9 The significantly increased MICs at 48 hours postinoculation may be the consequence of cfu rebound and bacteriostatic effect of AGE on these strains. The reliability of the clinical interpretation of this observation may undoubtedly require further tolerability testing of AGE in humans as a prelude to understanding garlic-induced plasma resistance to infections.
The observation that AGE elicited its antimicrobial potency in a dose-and time-dependent manner producing distinct time-kill profiles suggests variations in the growth inhibitory responses of the tested isolates to garlic. Similar responses have been observed in antibiotic-resistant E. coli, Enterobacter cloacae, and Citrobacter freundi. 15 However, the uniqueness of time-kill profiles of the gram-positives and gram-negatives in this study may be connected with their structurally different cell wall barriers. The lipid composition of cell wall has been found to have an influence on the permeability of hydrophobic and volatile bioactive substances in garlic. 41 The eukaryotic nature and ergosterol availability in Candida cell wall may also be crucial to the observed time-kill kinetics of AGE against our isolates.
In conclusion, the results of this study have provided scientific justification for the use of garlic extract in health products and herbal remedies against multidrug-resistant bacterial infections and candidiasis in Nigeria. Therefore, complementary and alternative medicine practices with plant extracts including garlic as a means of decreasing the burden of drug resistance and reducing the cost of management of diseases would be of clinical and public health importance in this country.
